How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

14,103 results for

E/M Medical Decision Making

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

8741. Health Supervision in the Management of Children and Adolescents With IBD: NASPGHAN Recommendations

copayments incurred as a result of hospitalization, office visits, or medication purchases. Because parents may be unlikely to discuss financial and personal constraints with their children’s medical providers, it is essential for physicians caring for children with IBD to recognize the broader effect of their patient’s illness on their family when making decisions about laboratory studies, need for hospitalization and testing, and choices of medications. DIAGNOSING CHILDREN AS HAVING IBD Pediatricians (...) Center, Cincin- nati, OH, the z Connecticut Children’s Medical Center, Hartford, CT, the § Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, the jj Department of Pediatrics, Janeway Child Health Centre, Memorial University of NL, St John’s, NL Canada, the Division of Pediatric Gastroenterology, Cohen Children’s Medical Center of New York, North Shore–Long Island Jewish Health System, New Hyde Park, NY, the # Seattle Children’s Hospital, University of Washington

2012 North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

8742. Diagnosis and Management of Hepatitis C Infection in Infants, Children, and Adolescents

(if cirrhosis is present) (2A; BII). Liver biopsy should be generally considered only if the result will influence medical decision making. Liver biopsy may be specifically useful to investigate unexplained clinical hepatic decompensation in a previously stable patient and in children who are being considered for antiviral treatment to assess severity of liver disease. It is reasonable to forego pretreatment liver biopsy in children with HCV genotypes 2 or 3 who have a high (>80%) probability of achieving (...) outcome and treatment effect must include assessments of growth and cognitive issues of CHC in children to assist in decision making on the timing of therapy. REFERENCES 1. ArmstrongGL,WasleyA,SimardEP,etal.Theprevalenceofhepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705–14. 2. Jhaveri R, Grant W, Kauf TL, et al. The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period. J Pediatr 2006;148:353–8. 3. Zou S

2012 North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

8743. Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families Full Text available with Trip Pro

if the index event is a sudden cardiac arrest (SCA). Additionally, many patients undergoing ICD implantation for primary prevention are surprised to learn of their potentially life-threatening condition. Regardless of the indication for an ICD, patients and their family members are thrust into high-stakes medical decision making and are required to confront and cope with their uncertain health condition, consider current and potential treatment options, and then adjust to a device implanted in the body (...) , RN, PhD, FAHA , RN, PhD, FAHA , and MD RN, PhDon behalf of the American Heart Association Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Council on Cardiovascular Disease in the Young Sandra B. Dunbar , Cynthia M. Dougherty , Samuel F. Sears , Diane L. Carroll , Nathan E. Goldstein , Daniel B. Mark , George McDaniel , Susan J. Pressler , Eleanor Schron , Paul Wang , and Vicki L. Zeigler and on behalf of the American Heart Association Council on Cardiovascular Nursing

2012 American Heart Association

8744. Guidelines for colonoscopy surveillance after screening and polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer

University School of Medicine, Indianapolis, Indiana; § Memorial Sloan-Kettering Cancer Center, New York, New York; Johns Hopkins University School of Medicine, Baltimore, Maryland; ¶ Eastern Virginia Medical School, Norfolk, Virginia; and # Kaiser Permanente Medical Center, Walnut Creek, California Podcast interview: www.gastro.org/gastropodcast. Also available on iTunes. S creening for colorectal cancer (CRC) in asymptomatic pa- tients can reduce the incidence and mortality of CRC. In the United (...) is that there is insuf?- cient evidence to make a recommendation. Shouldsurveillancebemodi?edbasedonlifestyle risk factors for CRC? There is considerable new evidence that risk of recurrent adenomas may be reduced by taking aspirin or nonsteroidal anti-in?ammatory drugs. 11,54 –57 We believe there is insuf?cient evidence to recommend any change in surveillance intervals in patients who are taking these medications. Should surveillance be modi?ed based on patient race, ethnicity, or sex? CRC age-adjusted risk varies

2012 American Society for Gastrointestinal Endoscopy

8745. Guidelines for endoscopy in pregnant and lactating women

recommendations are typically stated as “We recommend ” This guideline is intended to be an educational device to provide information that may assist endoscopists in providing care to patients. This guideline is not a rule and shouldnotbeconstruedasestablishingalegalstandardof careorasencouraging,advocating,requiring,ordiscour- aging any particular treatment. Clinical decisions in any particular case involve a complex analysis of the patient’s condition and available courses of action. Therefore, clin- ical (...) to the fetus include terato- genesis (from medications given to the mother and/or ionizing radiation exposure) and premature birth. 4 In sit- uations where therapeutic intervention is necessary, en- doscopy offers a relatively safe alternative to radiologic or surgicalinterventions. 3,5-10 Themainindicationsforendos- copy in pregnancy are outlined in Table 2, and general principles that apply to endoscopy in pregnancy are shown in Table 3. SAFETY DURING PREGNANCY OF MEDICATIONS COMMONLY USED FOR ENDOSCOPY

2012 American Society for Gastrointestinal Endoscopy

8746. Practice Advisory for Perioperative Visual Loss Associated with Spine Surgery

. How does this Advisory differ from existing guidelines? New evidence presented includes an updated evaluation of scientific literature. The new findings did not necessitate a change in recommendations. Why does this Advisory differ from existing guidelines? The ASA advisory differs from the existing guidelines because it provides new evidence obtained from recent scientific literature. PRACTICE Advisories are systematically developed reports that are intended to assist decision-making in areas (...) , Cornblath WT, Kline LB: Ischemic optic neuropathy after lumbar spine surgery. Arch Ophthalmol 1994; 112:925–31 Montero JA, Ruiz-Moreno JM, Galindo A, Fernandez-Muñoz M: Release hallucinations and visual loss as first manifestations of postoperative unilateral blindness. Eur J Ophthalmol 2007; 17:844–6 Roth S, Nunez R, Schreider BD: Unexplained visual loss after lumbar spinal fusion. J Neurosurg Anesthesiol 1997; 9:346–8 Stang-Veldhouse KN, Yeu E, Rothenberg DM, Mizen TR: Unusual presentation

2012 American Society of Anesthesiologists

8747. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions

, Charlottesville, VA; 9 University of FloridaCollegeofMedicine, Gainesville,FL; 10 HersheyMedical Center, Penn State University, Hershey, PA; and 11 Massachusetts General Hospital, Harvard Medical School, Boston, MA. Reprint requests to: Teresa M. Darragh, MD, Departments of Pathology and Obstetrics, Gynecology and Reproductive Sci- ence, University of California – San Francisco/Mt Zion Medical Center, 1600 Divisadero St, Room B618 San Francisco, CA 94115. E-mail: teresa.darragh@ucsf.edu (...) Service and the ASCCP and grants from the Gynecologic Oncology Group. R. Kevin Reynolds receives lecture fees from 1 University of California – San Francisco, San Francisco, CA; 2 Mount Sinai Hospital, Toronto, Ontario, Canada; 3 UMDNJ- New Jersey Medical School, Newark, NJ; 4 Mayo Clinic, Ro- chester, MN; 5 Quest Diagnostics, Teterboro, NJ; 6 Thomas Jefferson University, Philadelphia, PA; 7 Northwestern University Feinberg School of Medicine, Chicago, IL; 8 University of Virginia Health System

2012 College of American Pathologists

8748. Management of Hyperglycemia in Hospitalized Patients in Non-critical Care Setting Full Text available with Trip Pro

Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation 1 January 2012 Article Contents Article Navigation Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline Guillermo E. Umpierrez 1Emory University School of Medicine (G.E.U.), Atlanta, Georgia 30322 Search for other works by this author on: Richard Hellman 2Heart of America Diabetes (...) 5University of California San Diego Medical Center (G.A.M.), San Diego, California 92037 Search for other works by this author on: Victor M. Montori 6Mayo Clinic Rochester (V.M.M.), Rochester, Minnesota 55905 Search for other works by this author on: Jane J. Seley 7New York-Presbyterian Hospital/Weill Cornell Medical Center (J.J.S.), New York, New York 10065 Search for other works by this author on: Greet Van den Berghe 8Catholic University of Leuven (G.V.d.B.), 3000 Leuven, Belgium Search for other works

2012 The Endocrine Society

8749. Practice Advisory for Preanesthesia Evaluation

of perioperative assessment and management of the patient by the anesthesiologist. Selective preoperative tests ( i.e. , tests ordered after consideration of specific information obtained from sources such as medical records, patient interview, physical examination, and the type or invasiveness of the planned procedure and anesthesia) may assist the anesthesiologist in making decisions about the process of perioperative assessment and management. Decision-making parameters for specific preoperative tests (...) and anesthesia) may assist the anesthesiologist in making decisions about the process of perioperative assessment and management. Decision-making parameters for specific preoperative tests or for the timing of preoperative tests cannot be unequivocally determined from the available scientific literature. Specific tests and their timing should be individualized and based upon information obtained from sources such as the patient's medical record, patient interview, physical examination, and the type

2012 American Society of Anesthesiologists

8750. Clinical Consensus Statement: Appropriate Use of Computed Tomography for Paranasal Sinus Disease

& Allergy Services, Albany, New York, USA by this author for this author , , MD 2 2University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA by this author for this author , , MD 3 3Eastern Virginia Medical School, Norfolk, Virginia, USA by this author for this author , , MD, MPH 4 4Medical College of Wisconsin, Milwaukee, Wisconsin, USA by this author for this author , , MD 5 5University of Cincinnati College of Medicine, Cincinnati, Ohio, USA by this author for this author , , DDS 6 6New (...) York University Dental Center, New York, New York, USA by this author for this author , , MD 2 2University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA by this author for this author , , MD 7 7The Metrohealth System, Cleveland, Ohio, USA by this author for this author , , MD 8 8Cleveland Clinic Foundation, Cleveland, Ohio, USA by this author for this author , , MD 9 9George Washington University School of Medicine, Washington, DC, USA by this author for this author , , MD 10

2012 American Academy of Otolaryngology - Head and Neck Surgery

8751. Health Care for Lesbians and Bisexual Women

-taking behavior and disease transmission also was notable among lesbians and bisexual women. Education about the risks of STIs and dispelling the perception that transmission of STIs between women is negligible will help patients make informed decisions. All patients, regardless of sexual orientation, should be encouraged to use safe sex practices to reduce the risk of transmitting or acquiring STIs and HIV. Safe sex practices for lesbians and bisexual women include use of condoms on sex toys, gloves (...) Survey of Family Growth. Natl Health Stat Report 2011;36:1–36. Institute of Medicine. The health of lesbian, gay, bisexual, and transgender people: building a foundation for better understanding. Washington, DC: National Academies Press; 2011. Legal status: health impact for lesbian couples. ACOG Committee Opinion No. 428. American College of Obstetricians and Gynecologists. Obstet Gynecol 2009;113:469–72. O’Hanlan KA. Domestic partnership benefits at medical universities. JAMA 1999;282:1289–92

2012 American College of Obstetricians and Gynecologists

8752. Intimate Partner Violence

. American Medical Association. Diagnostic and treatment guidelines on domestic violence. Chicago (IL): AMA; 1992. Baram DA, Basson R. Sexuality, sexual dysfunction, and sexual assault. In: Berek JS, editor. Berek & Novak’s gynecology. 14th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2007. p. 313–49. Miller E, Decker MR, McCauley HL, Tancredi DJ, Levenson RR, Waldman J, et al. Pregnancy coercion, intimate partner violence and unintended pregnancy. Contraception 2010;81:316–22. Decker MR, Miller (...) E, McCauley HL, Tancredi DJ, Levenson RR, Waldman J, et al. Intimate partner violence and partner notification of sexually transmitted infections among adolescent and young adult family planning clinic patients. Int J STD AIDS 2011;22:345–7. Bauer HM, Gibson P, Hernandez M, Kent C, Klausner J, Bolan G. Intimate partner violence and high-risk sexual behaviors among female patients with sexually transmitted diseases. Sex Transm Dis 2002;29:411–6. Commonwealth Fund. Addressing domestic violence

2012 American College of Obstetricians and Gynecologists

8753. Radiotherapeutic and surgical management for newly diagnosed brain metastasis/es

Oncology, M.D. Anderson Cancer Center, Houston, Texas k Department of Radiation Oncology, Northwest Community Hospital, Arlington Heights, Illinois l Department of Radiation Oncology, Duke University Medical School, Durham, North Carolina m Department of RadiationOncology,University of Southern CaliforniaKeck Schoolof Medicine, LosAngeles,California n Department of Radiation Oncology, Ohio State University, Columbus, Ohio (deceased) Received 27 October 2011; revised 9 December 2011; accepted 15 (...) Case Medical Center, Cleveland, Ohio e DepartmentofRadiationOncology,CrossCancerInstitute,UniversityofAlberta,Edmonton,Canada(CAROrepresentative) f Department of Radiation Oncology, University of Colorado, Aurora, Colorado g University of Minnesota Gamma Knife Center and Minneapolis Radiation Oncology, Minneapolis, Minnesota h Department of Neurological Surgery, Cleveland Clinic, Cleveland, Ohio i Department of Radiation Oncology, Ohio State University, Columbus, Ohio j Department of Radiation

2012 American Society for Radiation Oncology

8754. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 Appropriate Use Criteria for Diagnostic Catheterization

heart, and/or coronary angiography) is performed in a manner consistent with established standards of care (8,9). 6. All indications for diagnostic catheterization were con- sidered with the following important assumptions: a. All indications were ?rst evaluated on the basis of the available medical literature. b. In many cases, studies published in the medical literature provide minimal information about the role of the test in clinical decision making. c. Appropriate use criteria development (...) , FCCP, FESC, FAHA, FSCAI‡‡ Andrea M. Russo, MD, FACC, FHRS§§ Matthew J. Sorrentino, MD, FACC‡‡ Mathew R. Williams, MD, FACC John B. Wong, MD, FACP‡‡ †American College of Physicians Representative; ‡Heart Failure Soci- ety of America Representative; §American Society of Nuclear Cardiol- ogy Representative; Society of Critical Care Medicine Representative; ¶American Heart Association Representative; #American Society of Echocardiography Representative; **Society of Cardiovascular Com- puted Tomography

2012 Society for Cardiovascular Angiography and Interventions

8755. KDIGO Clinical Practice Guideline for Glomerulonephritis (GN)

University Medical Center, New York, NY; 3 Johns Hopkins University School of Medicine, Baltimore, MD; 4 Perel- man School of Medicine, University of Pennsylvania, Philadel- phia, P A; 5 Cleveland Clinic, Cleveland, OH; 6 University of Michi- gan School of Medicine, Ann Arbor, MI; 7 Boston Children’s Hospital, Boston, MA; 8 New York University Langone Medical Center, New York, NY; and 9 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD. Address (...) correspondence to Michael J. Choi, MD, Department of Medicine, Division of Nephrology, Johns Hopkins University, 1830 E Monument St, Ste 416, Baltimore, MD 21287. E-mail: mchoi3@ jhmi.edu © 2013 by the National Kidney Foundation, Inc. 0272-6386/$36.00 http://dx.doi.org/10.1053/j.ajkd.2013.06.002 Am J Kidney Dis. 2013;62(3):403-441 403nephrologists, but other health care professionals in- volved in the care of patients with GN will ?nd it useful. The guideline addresses the following forms ofGN: ? Steroid

2012 National Kidney Foundation

8756. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary

of patient understanding and adherence may adversely affect outcomes, physicians and other health- care providers should make every effort to engage the patient’s active participation in prescribed medical regi- mens and lifestyles. In addition, patients should be informed of the risks, bene?ts, and alternatives to a particular treatment and should be involved in shared decision making whenever feasible, particularly for COR IIa and IIb, for which the bene?t-to-risk ratio may be lower. The Task Force (...) , Past Chair 2006 –2008§§ Cynthia D. Adams, MSN, APRN-BC, FAHA§§ Nancy M. Albert, PHD, CCNS, CCRN, FAHA Ralph G. Brindis, MD, MPH, MACC Christopher E. Buller, MD, FACC§§ Mark A. Creager, MD, FACC, FAHA David DeMets, PHD Steven M. Ettinger, MD, FACC§§ Robert A. Guyton, MD, FACC Judith S. Hochman, MD, FACC, FAHA Sharon Ann Hunt, MD, FACC, FAHA§§ Richard J. Kovacs, MD, FACC, FAHA Frederick G. Kushner, MD, FACC, FAHA§§ Bruce W. Lytle, MD, FACC, FAHA§§ Rick A. Nishimura, MD, FACC, FAHA§§ E. Magnus Ohman

2012 Society for Cardiovascular Angiography and Interventions

8757. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update

* Steven R. Bailey, MD, FACC, FSCAI§ Chirojit Mukherjee, MD†† John H. Calhoon, MD‡ Debabrata Mukherjee, MD, FACC* Blase A. Carabello, MD, FACC* Catherine M. Otto, MD, FACC* Milind Y. Desai, MBBS, FACC ¦¶ Carlos E. Ruiz, MD, PhD, FACC, FSCAI§ Fred H. Edwards, MD, FACC† Ralph L. Sacco, MD, MS, FAHA‡‡ Gary S. Francis, MD, FACC# Donnette Smith§§ Timothy J. Gardner, MD, FACC† James D. Thomas, MD, FACC ¦¦ ACCF Task Force Members Robert A. Harrington, MD, FACC, Chair Deepak L. Bhatt, MD, MPH, FACC, Vice Chair (...) in life, the onset of symptoms still heralds a rapid decline with medical therapy alone (15). 10 2.2. Diagnosis 2.2.1. Echocardiography Versus Catheterization Assessment of the severity of stenosis does not differ in TAVR patients compared with the general AS population, and decisions should therefore be based upon established guidelines (18). Although invasive cardiac catheterization has historically been the standard for quantification of AS, this function has been largely replaced

2012 Society for Cardiovascular Angiography and Interventions

8758. ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease (SIHD)

of patient understanding and adherence may adversely affect outcomes, physicians and other health- care providers should make every effort to engage the patient’s active participation in prescribed medical regi- mens and lifestyles. In addition, patients should be informed of the risks, bene?ts, and alternatives to a particular treatment and should be involved in shared decision making whenever feasible, particularly for COR IIa and IIb, for which the bene?t-to-risk ratio may be lower. The Task Force (...) , Past Chair 2006 –2008§§ Cynthia D. Adams, MSN, APRN-BC, FAHA§§ Nancy M. Albert, PHD, CCNS, CCRN, FAHA Ralph G. Brindis, MD, MPH, MACC Christopher E. Buller, MD, FACC§§ Mark A. Creager, MD, FACC, FAHA David DeMets, PHD Steven M. Ettinger, MD, FACC§§ Robert A. Guyton, MD, FACC Judith S. Hochman, MD, FACC, FAHA Sharon Ann Hunt, MD, FACC, FAHA§§ Richard J. Kovacs, MD, FACC, FAHA Frederick G. Kushner, MD, FACC, FAHA§§ Bruce W. Lytle, MD, FACC, FAHA§§ Rick A. Nishimura, MD, FACC, FAHA§§ E. Magnus Ohman

2012 Society for Cardiovascular Angiography and Interventions

8759. ST-Elevation Myocardial Infarction: Guideline For the Management of

adversely affect outcomes, physicians and other healthcare providers should make every effort to engage the patient’s active participation in prescribed medical regimens and lifestyles. In addition, patients should be informed of the risks, bene?ts, and alternatives to a particular treatment and should be involved in shared decision making whenever feasible, particularly for COR IIa and IIb, for which the bene?t-to-risk ratio may be lower. The Task Force makes every effort to avoid actual, poten- tial (...) †; Frederick G. Kushner, MD, FACC, FAHA, FSCAI, Vice Chair*†; Deborah D. Ascheim, MD, FACC†; Donald E. Casey, Jr, MD, MPH, MBA, FACP, FAHA‡; Mina K. Chung, MD, FACC, FAHA*†; James A. de Lemos, MD, FACC*†; Steven M. Ettinger, MD, FACC*§; James C. Fang, MD, FACC, FAHA*†; Francis M. Fesmire, MD, FACEP*¶; Barry A. Franklin, PHD, FAHA†; Christopher B. Granger, MD, FACC, FAHA*†; Harlan M. Krumholz, MD, SM, FACC, FAHA†; Jane A. Linderbaum, MS, CNP-BC†; David A. Morrow, MD, MPH, FACC, FAHA*†; L. Kristin Newby, MD

2012 American College of Cardiology

8760. Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management Full Text available with Trip Pro

3.3.3.2. Autism Spectrum Disorders 1156 3.3.3.3. Fine and Gross Motor Skills 1156 3.4. Make Referrals for Early Intervention and Formal Developmental and Medical Evaluation 1157 3.5. Formal Developmental and Medical Evaluation 1157 3.5.1. Individualized Approach 1157 3.5.2. Genetic Evaluation 1157 3.5.2.1. Early Identification 1157 3.5.2.2. Latent and Subtle Phenotypes 1158 3.5.2.3. Specialized or Advanced Analyses 1158 3.5.3. Structural Brain Imaging 1158 3.5.4. Age-specific Neurodevelopmental (...) with that syndrome, rather than general milestones). 3.3.1.3. Make Accurate and Informed Observations of the Child Observation of a child's development by the medical home providers during all medical home visits remains an important part of overall surveillance. 3.3.1.4. Identify the Presence of Risk and Protective Factors CHD itself is a significant risk factor for developmental problems. Specific risk factors may be identified through past medical history, perioperative course, and presence of a known genetic

2012 American Heart Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>